Axecap Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$446K Hold
5,146
0.31% 48
2025
Q4
$494K Sell
5,146
-62
-1% -$6.02K 0.3% 59
2025
Q3
$496K Sell
5,208
-16
-0.3% -$1.47K 0.31% 67
2025
Q2
$455K Hold
5,224
0.3% 63
2025
Q1
$469K Hold
5,224
0.4% 55
2024
Q4
$417K Hold
5,224
0.31% 56
2024
Q3
$470K Buy
+5,224
New +$439K 0.36% 60

Other funds holding MDT

Axecap Investments's MDT Position: Q1 2026 in Review

Axecap Investments held its Medtronic (MDT) position steady in Q1 2026 at 5,146 shares worth $446K. The position accounts for 0.31% of the portfolio, ranked #48.

Axecap Investments first reported a position in MDT in Q3 2024 and has held it in 7 quarters since. The position peaked at $496K in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Axecap Investments held 5,146 shares of Medtronic worth $446K as of Q1 2026.
  • Axecap Investments left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up 0.31% of Axecap Investments's portfolio in Q1 2026, its #48 holding.
  • Axecap Investments first reported a position in Medtronic in Q3 2024 and has held it in 7 quarters since.
  • Axecap Investments's Medtronic position peaked at $496K in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Axecap Investments's 13F filing for Q1 2026, filed 20 Apr 2026.